This is noteworthy because BRAF mutation is recognized as risk factor for thyroid cancer progression [1, 3] and because, so far, KRAS proteins have proved very difficult to be directly targeted [15]. The gene discussed is KRAS; the disease is thyroid gland carcinoma.